Topical Drug Delivery Market by Type (Semisolids (Creams, Ointments, Gels, Lotions), Liquids, Solids, Transdermal Products), Route (Dermal, Ophthalmic, Rectal, Vaginal, Nasal), Facility of Use (Homecare, Hospital, Burn Center) - Global Forecast to 2024

局所薬物デリバリーの世界市場予測(~2024年)

◆タイトル:Topical Drug Delivery Market by Type (Semisolids (Creams, Ointments, Gels, Lotions), Liquids, Solids, Transdermal Products), Route (Dermal, Ophthalmic, Rectal, Vaginal, Nasal), Facility of Use (Homecare, Hospital, Burn Center) - Global Forecast to 2024
◆商品コード:MAM90943
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年8月20日
◆ページ数:189
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、局所薬物デリバリーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別(半固体(クリーム、軟膏、ゲル、ローション)、液体、固体、経皮製剤)分析、経路別(皮膚、眼、直腸、膣、鼻)分析、利用施設別(在宅、病院、バーンセンター)分析、局所薬物デリバリーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、局所薬物デリバリーの世界市場規模が2019年932億ドルから2024年1232億ドルまで年平均5.7%成長すると予測しています。

“The topical drug delivery market is projected to grow at a CAGR of 5.7% during the forecast period (2019–2024).”The topical drug delivery market is projected to reach USD 123.2 billion by 2024 from USD 93.2 billion in 2019, at a CAGR of 5.7%. The growth of the topical drug delivery market is driven mainly by the high prevalence of skin disease, rising incidences of eye diseases, high incidence of burn injuries, and the growing prevalence of diabetes. Additionally, emerging markets such as China and India are expected to offer potential growth opportunities to market players in the coming years. However, preference for alternative modes of drug delivery such as oral, injectables, pulmonary, among others could restrict the growth of this market.

“By product, the semi-solid formulations segment is expected to account for the largest share of the topical drug delivery market”
Based on product, the topical drug delivery market is segmented into semi-solid formulations (creams, gels, ointments, pastes, and lotions), solid formulations (suppositories and powders), liquid formulations (solutions and suspensions), and transdermal products (transdermal patches and transdermal semi-solids). The semi-solid formulations segment is expected to account the largest market share of the topical drug delivery market in 2019. This is mainly due to their easy application and ability to topically deliver a wide variety of drug molecules compared to other formulations.

“By route of administration, dermal drug delivery segment to dominate the topical drug delivery market during the forecast period”
The dermal drug delivery segment accounted for the largest share of the market in 2018. This is mainly due to the high prevalence of skin diseases across the globe. For instance, According to the WHO, between 2 and 3 million cases of non-melanoma skin cancer and 132,000 cases of melanoma skin cancer are diagnosed annually across the globe.

“By facility of use, homecare settings segment to dominate the topical drug delivery market during the forecast period”
The homecare settings segment accounted for the largest share of the market in 2018. This is mainly due to the ease of use of topical products at home, better affordability, and advantages of topical and transdermal patches for patients who require a constant drug level as well as those suffering from chronic diseases at homecare settings.

“North America is expected to witness the highest growth during the forecast period.”
North America is expected to account for the largest share of the global topical drug delivery market in 2019, followed by Europe. However, Japan is expected to witness the highest CAGR during the forecast period. This can primarily be attributed to the rising geriatric population, increasing the inflow of generic drugs, a growing number of product approvals and launches, and the increasing focus of local players on the R&D of topical formulations in the country. For instance, in November 2018, Santen Pharmaceutical Co., Ltd. (Japan) and Ube Industries (Japan) launched the topical EYBELIS Ophthalmic Solution 0.002% in Japan. Similarly, in September 2018, Santen Pharmaceutical Co., Ltd. (Japan) signed a development and drug discovery agreement with PeptiDerm Inc. (Japan) for developing topical ophthalmic products. Furthermore, in June 2017, LEO Pharma (Denmark) partnered with Kyowa Hakko Kirin Co., Ltd. (Japan) for the development of a topical gel formulation for the treatment of psoriasis.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–55%, Tier 2–25%, and Tier 3–20%
• By Designation: C-level–43%, Director-level–32%, and Others–25%
• By Region: North America–38%, Europe–29%, Asia Pacific–23%, Rest of World–10%

The prominent players in the topical drug delivery market are Nestle SA (Switzerland), Johnson & Johnson (US), Bausch Health Companies (Canada), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bayer AG (Germany), Hisamitsu Pharmaceutical (Japan), Mylan (US) Glenmark Pharmaceuticals (India), Cipla Ltd (India), Crescita Therapeutics Inc. (Canada), and Merck & Co (US).

Research Coverage:
The report analyzes the topical drug delivery market and aims at estimating the market size and future growth potential of the topical drug delivery market and the different segments such as dermal, ophthalmic, rectal, vaginal, and nasal drug delivery. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the topical drug delivery market.
• Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launch in the topical drug delivery market.
• Market Development: Comprehensive information on lucrative emerging regions.
• Market Diversification: Exhaustive information about new products and services, growing geographies, and recent developments in the global topical drug delivery market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of the leading players in the topical drug delivery market.

【レポートの目次】

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 23)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.2.3 Growth Forecast
2.3 Market Data Validation and Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 32)
4 Premium Insights (Page No. – 35)
4.1 Market Overview
4.2 North America: Market, By Product, 2018
4.3 Europe: Market, By Facility of Use, 2018
4.4 Market: Geographic Snapshot
5 Market Overview (Page No. – 39)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence of Skin Diseases
5.2.1.2 Rising Prevalence of Eye Diseases
5.2.1.3 High Incidence of Burn Injuries
5.2.1.4 Growing Prevalence of Diabetes
5.2.2 Restraints
5.2.2.1 Preference for Alternative Modes of Drug Delivery
5.2.3 Opportunities
5.2.3.1 Delivery of Biologics Through the Transdermal Route
5.2.3.2 Self-Administration and Home Care
5.2.4 Challenges
5.2.4.1 Technical Barriers Related to Skin Irritation and Permeability
5.2.4.2 Drug Failures and Product Recalls
6 Topical Drug Delivery Market, By Product (Page No. – 44)
6.1 Introduction
6.2 Semi-Solid Formulations
6.2.1 Creams
6.2.1.1 Ease of Spreadability and Washability to Drive This Market Segment
6.2.2 Ointments
6.2.2.1 Ointments are Widely Used in Analgesic Indications
6.2.3 Lotions
6.2.3.1 Easy Administration of Lotions to Drive Their Demand Among End Users
6.2.4 Gels
6.2.4.1 Faster Drug Release and Greater Patient Acceptability to Drive the Market for Topical Gels
6.2.5 Pastes
6.2.5.1 Topical Pastes are Widely Used for the Treatment and Prevention of Skin Irritation
6.3 Liquid Formulations
6.3.1 Suspensions
6.3.1.1 Higher Rate of Bioavailability and Controlled Onset of Action to Support the Growth of the Topical Suspensions Market
6.3.2 Solutions
6.3.2.1 Topical Solutions Comprise Soluble Chemicals That are Dissolved in Various Solvents
6.4 Solid Formulations
6.4.1 Powders
6.4.1.1 Powders have A Very Fine Particle Size That Covers A Large Surface Area Per Unit Weight
6.4.2 Suppositories
6.4.2.1 Suppositories Require A Suitable Base That Ensures the Compatibility and Stability of the Drug
6.5 Transdermal Products
6.5.1 Transdermal Patches
6.5.1.1 Transdermal Patches to Account for the Largest Share of the Transdermal Drug Delivery Market in 2019
6.5.2 Transdermal Semi-Solids
6.5.2.1 Transdermal Semi-Solids Segment to Witness Negative Growth During the Forecast Period
7 Topical Drug Delivery Market, By Route of Administration (Page No. – 65)
7.1 Introduction
7.2 Dermal Drug Delivery
7.2.1 Dermal Drug Delivery is the Largest Segment in This Market Due to Advantages Such as Ease of Use and Increased Patient Compliance
7.3 Ophthalmic Drug Delivery
7.3.1 Increasing Use of Mobile Devices is Likely to Impact Vision, Which is A Key Factor Supporting Market Growth
7.4 Rectal Drug Delivery
7.4.1 Poor Absorption of Drugs Through the Rectal Route—A Key Disadvantage Associated With This Market Segment
7.5 Vaginal Drug Delivery
7.5.1 High Permeability of Vaginal Tissues, the Scope of Self-Administration, and Ease of Manufacturing are Expected to Boost the Growth of the Vaginal Drug Delivery Market Segment
7.6 Nasal Drug Delivery
7.6.1 Absence of Drug Degradation, High Efficacy of Nasally Administered Drugs, and Growing Preference for Self-Administration to Drive Market Growth
8 Topical Drug Delivery Market, By Facility of Use (Page No. – 72)
8.1 Introduction
8.2 Home Care Settings
8.2.1 Home Care Settings Accounted for the Largest Share in 2018
8.3 Hospitals and Clinics
8.3.1 Rising Incidence of Surgical Site Infections to Drive This Segment
8.4 Burn Centers
8.4.1 High Incidence of Burn Injuries Across the Globe to Support the Market Growth
8.5 Other Facilities
9 Topical Drug Delivery Market, By Region (Page No. – 78)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Rising Prevalence of Skin Diseases and the Approval and Launch of Innovative Topical Formulations—Key Factors Driving Market Growth
9.2.2 Canada
9.2.2.1 Rising Prevalence of Skin Diseases and Funding for the Development of Topical Drugs to Drive Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Growing Focus of Pharmaceutical Companies on the Development of Topical Products to Drive Market Growth
9.3.2 UK
9.3.2.1 Rising Prevalence of Skin Diseases & Chronic Conditions to Drive Market Growth
9.3.3 France
9.3.3.1 Rising Prevalence of Skin Diseases and Development of Topical Drugs By Local Players to Support Market Growth
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Increasing Number of Product Approvals and Growing Focus of Local Players on the R&D of Topical Formulations to Support Market Growth
9.4.2 China
9.4.2.1 Growing Focus of Major Players in China on the Development of Topical Drugs to Drive Market Growth
9.4.3 India
9.4.3.1 Rising Awareness Among Healthcare Providers & Patients and Increasing Focus on Noninvasive Methods of Drug Delivery to Drive Market Growth
9.4.4 Rest of Asia Pacific
9.5 Rest of the World
10 Competitive Landscape (Page No. – 145)
10.1 Overview
10.2 Market Share Analysis
10.2.1 Johnson & Johnson
10.2.2 Nestlé Sa (Galderma)
10.2.3 Novartis
10.3 Competitive Scenario
10.3.1 Product Launches
10.3.2 Expansions
10.3.3 Agreements and Collaborations
10.3.4 Acquisitions
10.4 Competitive Leadership Mapping (Overall Market) (2018)
10.4.1 Visionary Leaders
10.4.2 Innovators
10.4.3 Dynamic Differentiators
10.4.4 Emerging Companies
11 Company Profiles (Page No. – 150)
(Business Overview, Products Offered, Recent Developments, MnM View
11.1 Glaxosmithkline
11.2 Janssen Global Services (A Subsidiary of Johnson & Johnson)
11.3 Bausch Health Companies
11.4 Merck & Co.
11.5 Bayer AG
11.6 Hisamitsu Pharmaceutical
11.7 Nestlé Sa
11.8 Novartis AG
11.9 Glenmark Pharmaceuticals
11.10 Cipla
11.11 Crescita Therapeutics Inc.
11.12 Mylan N.V.
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 182)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Related Reports
12.4 Author Details

List of Tables (143 Figures)
Table 1 Topical Drug Delivery Market, By Product, 2017–2024 (USD Million)
Table 2 Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 3 Market for Semi-Solid Formulations, By Country, 2017–2024 (USD Million)
Table 4 Market for Creams, By Country, 2017–2024 (USD Million)
Table 5 Market for Ointments, By Country, 2017–2024 (USD Million)
Table 6 Market for Lotions, By Country, 2017–2024 (USD Million)
Table 7 Market for Gels, By Country, 2017–2024 (USD Million)
Table 8 Market for Pastes, By Country, 2017–2024 (USD Million)
Table 9 Topical Drug Delivery Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 10 Market for Liquid Formulations, By Country, 2017–2024 (USD Million)
Table 11 Market for Suspensions, By Country, 2017–2024 (USD Million)
Table 12 Market for Solutions, By Country, 2017–2024 (USD Million)
Table 13 Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 14 Market for Solid Formulations, By Country, 2017–2024 (USD Million)
Table 15 Topical Drug Delivery Market for Powders, By Country, 2017–2024 (USD Million)
Table 16 Market for Suppositories, By Country, 2017–2024 (USD Million)
Table 17 Comparison Between Transdermal Patches and Transdermal Semi-Solid Formulations
Table 18 Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 19 Market for Transdermal Products, By Country, 2017–2024 (USD Million)
Table 20 Market for Transdermal Patches, By Country, 2017–2024 (USD Million)
Table 21 Market for Transdermal Semi-Solids, By Country, 2017–2024 (USD Million)
Table 22 Topical Drug Delivery Market, By Route of Administration, 2017–2024 (USD Million)
Table 23 Dermal Drug Delivery Market, By Country, 2017–2024 (USD Million)
Table 24 Ophthalmic Drug Delivery Market, By Country, 2017–2024 (USD Million)
Table 25 Rectal Drug Delivery Market, By Country, 2017–2024 (USD Million)
Table 26 Vaginal Drug Delivery Market, By Country, 2017–2024 (USD Million)
Table 27 Nasal Drug Delivery Market, By Country, 2017–2024 (USD Million)
Table 28 Market, By Facility of Use, 2017–2024 (USD Million)
Table 29 Topical Drug Delivery Market for Home Care Settings, By Country, 2017–2024 (USD Million)
Table 30 Market for Hospitals & Clinics, By Country, 2017–2024 (USD Million)
Table 31 Market for Burn Centers, By Country, 2017–2024 (USD Million)
Table 32 Market for Other Facilities, By Country, 2017–2024 (USD Million)
Table 33 Market, By Country, 2017–2024 (USD Million)
Table 34 North America: Market, By Country, 2017–2024 (USD Million)
Table 35 North America: Market, By Route of Administration, 2017–2024 (USD Million)
Table 36 North America: Market, By Product, 2017–2024 (USD Million)
Table 37 North America: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 38 North America: Topical Drug Delivery Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 39 North America: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 40 North America: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 41 North America: Market, By Facility of Use, 2017–2024 (USD Million)
Table 42 Product Approvals & Launches in the US Market (2017–2019)
Table 43 US: Market, By Route of Administration, 2017–2024 (USD Million)
Table 44 US: Market, By Product, 2017–2024 (USD Million)
Table 45 US: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 46 US: Topical Drug Delivery Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 47 US: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 48 US: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 49 US: Market, By Facility of Use, 2017–2024 (USD Million)
Table 50 Canada: Market, By Route of Administration, 2017–2024 (USD Million)
Table 51 Canada: Market, By Product, 2017–2024 (USD Million)
Table 52 Canada: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 53 Canada: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 54 Canada: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 55 Canada: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 56 Canada: Market, By Facility of Use, 2017–2024 (USD Million)
Table 57 Recent Developments in the European Topical Drug Delivery Market, 2015–2018
Table 58 Europe: Market, By Country, 2017–2024 (USD Million)
Table 59 Europe: Market, By Route of Administration, 2017–2024 (USD Million)
Table 60 Europe: Market, By Product, 2017–2024 (USD Million)
Table 61 Europe: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 62 Europe: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 63 Europe: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 64 Europe: Topical Drug Delivery Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 65 Europe: Market, By Facility of Use, 2017–2024 (USD Million)
Table 66 Developments in the Field of Topical Drug Delivery in Germany, 2017–2019
Table 67 Germany: Market, By Route of Administration, 2017–2024 (USD Million)
Table 68 Germany: Market, By Product, 2017–2024 (USD Million)
Table 69 Germany: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 70 Germany: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 71 Germany: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 72 Germany: Topical Drug Delivery Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 73 Germany: Market, By Facility of Use, 2017–2024 (USD Million)
Table 74 Developments in the Market in the Uk, 2016–2019
Table 75 UK: Market, By Route of Administration, 2017–2024 (USD Million)
Table 76 UK: Market, By Product, 2017–2024 (USD Million)
Table 77 UK: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 78 UK: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 79 UK: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 80 UK: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 81 UK: Topical Drug Delivery Market, By Facility of Use, 2017–2024 (USD Million)
Table 82 France: Market, By Route of Administration, 2017–2024 (USD Million)
Table 83 France: Market, By Product, 2017–2024 (USD Million)
Table 84 France: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 85 France: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 86 France: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 87 France: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 88 France: Market, By Facility of Use, 2017–2024 (USD Million)
Table 89 RoE: Market, By Route of Administration, 2017–2024 (USD Million)
Table 90 RoE: Topical Drug Delivery Market, By Product, 2017–2024 (USD Million)
Table 91 RoE: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 92 RoE: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 93 RoE: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 94 RoE: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 95 RoE: Market, By Facility of Use, 2017–2024 (USD Million)
Table 96 Developments in the Topical Drug Delivery Market in the Asia Pacific, 2016–2019
Table 97 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 98 Asia Pacific: Market, By Route of Administration, 2017–2024 (USD Million)
Table 99 Asia Pacific: Market, By Product, 2017–2024 (USD Million)
Table 100 Asia Pacific: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 101 Asia Pacific: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 102 Asia Pacific: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 103 Asia Pacific: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 104 Asia Pacific: Market, By Facility of Use, 2017–2024 (USD Million)
Table 105 Japan: Market, By Route of Administration, 2017–2024 (USD Million)
Table 106 Japan: Topical Drug Delivery Market, By Product, 2017–2024 (USD Million)
Table 107 Japan: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 108 Japan: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 109 Japan: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 110 Japan: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 111 Japan: Market, By Facility of Use, 2017–2024 (USD Million)
Table 112 China: Market, By Route of Administration, 2017–2024 (USD Million)
Table 113 China: Market, By Product, 2017–2024 (USD Million)
Table 114 China: Topical Drug Delivery Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 115 China: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 116 China: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 117 China: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 118 China: Market, By Facility of Use, 2017–2024 (USD Million)
Table 119 India: Market, By Route of Administration, 2017–2024 (USD Million)
Table 120 India: Market, By Product, 2017–2024 (USD Million)
Table 121 India: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 122 India: Topical Drug Delivery Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 123 India: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 124 India: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 125 India: Market, By Facility of Use, 2017–2024 (USD Million)
Table 126 RoAPAC: Market, By Route of Administration, 2017–2024 (USD Million)
Table 127 RoAPAC: Market, By Product, 2017–2024 (USD Million)
Table 128 RoAPAC: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 129 RoAPAC: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 130 RoAPAC: Topical Drug Delivery Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 131 RoAPAC: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 132 RoAPAC: Market, By Facility of Use, 2017–2024 (USD Million)
Table 133 RoW: Market, By Route of Administration, 2017–2024 (USD Million)
Table 134 RoW: Market, By Product, 2017–2024 (USD Million)
Table 135 RoW: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 136 RoW: Topical Drug Delivery Market for Liquid Formulations Market, By Type, 2017–2024 (USD Million)
Table 137 RoW: Market for Solid Formulations Market, By Type, 2017–2024 (USD Million)
Table 138 RoW: Market for Transdermal Products Market, By Type, 2017–2024 (USD Million)
Table 139 RoW: Market, By Facility of Use, 2017–2024 (USD Million)
Table 140 Product Launches
Table 141 Expansions
Table 142 Agreements and Collaborations
Table 143 Acquisitions

List of Figures (38 Figures)
Figure 1 Topical Drug Delivery Market Segmentation
Figure 2 Market: Research Methodology
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Market Share, By Product, 2018
Figure 9 Topical Drug Delivery Market Share, By Route of Administration, 2018
Figure 10 Market Share, By Facility of Use, 2018
Figure 11 Geographic Snapshot: Market, 2018
Figure 12 High Prevalence of Skin Diseases and High Incidence of Burn Injuries to Drive the Growth of the Market
Figure 13 Semi-Solid Formulations to Dominate the North American Market During the Forecast Period
Figure 14 Home Care Settings to Dominate the European Market During the Forecast Period
Figure 15 US to Grow at the Highest CAGR During the Forecast Period
Figure 16 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Semi-Solid Formulations Segment to Command the Largest Share of the Market in 2019
Figure 18 Dermal Drug Delivery to Dominate the Market During the Forecast Period
Figure 19 Home Care Settings Segment to Command the Largest Share of the Market in 2019
Figure 20 Market, By Region, 2019 vs 2024
Figure 21 North America: Topical Drug Delivery Market Snapshot
Figure 22 Europe: Market Snapshot
Figure 23 Asia Pacific: Market Snapshot
Figure 24 Rest of the World: Market Snapshot
Figure 25 Market Share Analysis By Key Players (2018)
Figure 26 Topical Drug Delivery Market (Global) Competitive Leadership Mapping, 2018
Figure 27 Glaxosmithkline PLC: Company Snapshot
Figure 28 Johnson & Johnson: Company Snapshot
Figure 29 Bausch Health Companies: Company Snapshot
Figure 30 Merck & Co.: Company Snapshot
Figure 31 Bayer AG.: Company Snapshot
Figure 32 Hisamitsu Pharmaceutical: Company Snapshot
Figure 33 Nestlé SA: Company Snapshot
Figure 34 Novartis AG: Company Snapshot
Figure 35 Glenmark Pharmaceuticals: Company Snapshot
Figure 36 Cipla: Company Snapshot
Figure 37 Crescita Therapeutics: Company Snapshot (2018)
Figure 38 Mylan: Company Snapshot (2018)

★調査レポート[局所薬物デリバリーの世界市場予測(~2024年)] ( Topical Drug Delivery Market by Type (Semisolids (Creams, Ointments, Gels, Lotions), Liquids, Solids, Transdermal Products), Route (Dermal, Ophthalmic, Rectal, Vaginal, Nasal), Facility of Use (Homecare, Hospital, Burn Center) - Global Forecast to 2024 / MAM90943) 販売に関する免責事項
[局所薬物デリバリーの世界市場予測(~2024年)] ( Topical Drug Delivery Market by Type (Semisolids (Creams, Ointments, Gels, Lotions), Liquids, Solids, Transdermal Products), Route (Dermal, Ophthalmic, Rectal, Vaginal, Nasal), Facility of Use (Homecare, Hospital, Burn Center) - Global Forecast to 2024 / MAM90943) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆